• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Implementation of Alere i Influenza A & B point of care test for the diagnosis of influenza in an emergency department

tetano

Editor, Senior Moderator
Am J Emerg Med. 2017 Oct 18. pii: S0735-6757(17)30853-7. doi: 10.1016/j.ajem.2017.10.046. [Epub ahead of print]
[h=1]Implementation of Alere i Influenza A & B point of care test for the diagnosis of influenza in an emergency department.[/h] Trabattoni E[SUP]1[/SUP], Le V[SUP]2[/SUP], Pilmis B[SUP]3[/SUP], Pean de Ponfilly G[SUP]2[/SUP], Caisso C[SUP]1[/SUP], Couzigou C[SUP]4[/SUP], Vidal B[SUP]4[/SUP], Mizrahi A[SUP]2[/SUP], Ganansia O[SUP]1[/SUP], Le Monnier A[SUP]2[/SUP], Lina B[SUP]5[/SUP], Nguyen Van JC[SUP]6[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]STUDY OBJECTIVE:[/h] This study aimed to evaluate the impact of implementing rapid point-of-care testing (POCT) with the Alere i Influenza A & B in an emergency department (ED) during an influenza epidemic.
[h=4]METHODS:[/h] Direct nasal swabs were prospectively collected following the physical examination of patients aged >18years who presented to the ED of a tertiary hospital in France with influenza-like illness (ILI) symptoms (N=301) between February 1st and March 31st, 2016, which coincided with an influenza epidemic. Laboratory-based testing (standard of care) was used to obtain a diagnosis in February 2016 (pre-POCT cohort) and positive results were confirmed using polymerase chain reaction. The primary endpoint was patient time in the ED.
[h=4]RESULTS:[/h] A total of 169 and 132 patients participated in the pre-POCT phase and POCT phase respectively. A significantly higher proportion of patients received a positive diagnosis in the POCT cohort compared with the pre-POCT cohort (31% versus 5.3%, P<0.01). Mean time spent in the ED and hospitalization rate were significantly lower in the POCT cohort (6.06h versus 4.15h, P=0.03, and 44.4% versus 9.7%, P=0.02, respectively). Despite similar rates in the prescription of antibiotics and antiviral therapies, the proportion of patients who were referred for additional tests was significantly lower in the POCT cohort (78.1% versus 62.1%, P=0.003, and 80.5% versus 63.6%, P=0.01, respectively).
[h=4]CONCLUSIONS:[/h] The Alere i Influenza A & B POCT reduced the length of stay in ED, the hospitalization rates, and the number of additional diagnostic tests compared with standard of care testing.
Copyright ? 2017 Elsevier Inc. All rights reserved.


PMID: 29137903 DOI: 10.1016/j.ajem.2017.10.046
 
Back
Top Bottom